Diploma PLC (LON:DPLM - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 4,609.28 ($62.39) and traded as high as GBX 5,487.50 ($74.28). Diploma shares last traded at GBX 5,440 ($73.63), with a volume of 175,203 shares trading hands.
Wall Street Analysts Forecast Growth
Several analysts have commented on the stock. Shore Capital restated a "hold" rating and set a GBX 5,100 price objective on shares of Diploma in a research note on Thursday, July 17th. JPMorgan Chase & Co. restated a "neutral" rating and set a GBX 4,440 price objective on shares of Diploma in a research note on Wednesday, August 6th. Finally, Berenberg Bank restated a "buy" rating and set a GBX 5,750 price objective on shares of Diploma in a research note on Tuesday, September 2nd. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of GBX 5,097.50.
Check Out Our Latest Stock Report on DPLM
Diploma Stock Performance
The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. The stock has a market capitalization of £7.29 billion, a PE ratio of 4,376.51, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The firm's fifty day moving average price is GBX 5,260.35 and its two-hundred day moving average price is GBX 4,609.28.
Diploma Company Profile
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.